Biomarin Pharmaceutical (BMRN) EBIT (2009 - 2026)
Biomarin Pharmaceutical (BMRN) posted EBIT of $110.92 million for Q2 2026, down 59.9% from $276.89 million a year earlier and down 14.4% from the prior quarter.
Powered by 
Analysis
Biomarin Pharmaceutical (BMRN) EBIT (2009 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBIT at Biomarin Pharmaceutical was $149.26 million, down 80.8% year-over-year; for FY2025, it came in at $409.48 million, down 15.4% from FY2024.
- In prior years, Biomarin Pharmaceutical's EBIT was $484.21 million in FY2024 (+160.6%), $185.77 million in FY2023 (+15.4%), $160.97 million in FY2022 and -$82.34 million in FY2021.
- Quarterly EBIT has run from a low of -$65.88 million in Q4 2021 to a high of $276.89 million in Q2 2025 over five years.
- On a year-over-year basis, EBIT increased in four of the last six quarters, with growth averaging 157.6%.
- The strongest year-over-year quarter for EBIT in the past five years was Q4 2024, with growth of 491.7%; the weakest was Q2 2026, with a decline of 59.9%.
- According to Business Quant data, EBIT for the three prior quarters was $129.64 million (Q1 2026), -$44.61 million (Q4 2025) and -$46.69 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 7.14 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 6.43 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | -584.00 Mn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 4.75 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 3.16 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 3.51 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | -10.39 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 4.27 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 1.25 Bn |
| 10 | Biomarin Pharmaceutical | 11.59 Bn | 5.45 Bn | 786.91 Mn | 110.92 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 110.92 Mn |
| Mar 31, 2026 | 129.64 Mn |
| Dec 31, 2025 | -44.61 Mn |
| Sep 30, 2025 | -46.69 Mn |
| Jun 30, 2025 | 276.89 Mn |
| Mar 31, 2025 | 223.89 Mn |
| Dec 31, 2024 | 161.41 Mn |
| Sep 30, 2024 | 113.89 Mn |
| Jun 30, 2024 | 120.45 Mn |
| Mar 31, 2024 | 88.46 Mn |
| Dec 31, 2023 | 27.28 Mn |
| Sep 30, 2023 | 30.53 Mn |
| Jun 30, 2023 | 65.57 Mn |
| Mar 31, 2023 | 62.40 Mn |
| Dec 31, 2022 | -13.09 Mn |
| Sep 30, 2022 | -2.42 Mn |
| Jun 30, 2022 | 39.15 Mn |
| Mar 31, 2022 | 137.33 Mn |
| Dec 31, 2021 | -65.88 Mn |
| Sep 30, 2021 | -53.22 Mn |
API Access
Biomarin Pharmaceutical EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=BMRN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "BMRN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=BMRN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();